Forte Biosciences News

Forte Biosciences | 8-K: Current report

Aug 30 16:08 ET

Forte Biosciences | 8-K: Current report

Aug 22 16:10 ET

Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE

Aug 14 16:44 ET

Forte Biosciences | DEF 14A: Definitive information statements

Jul 30 22:20 ET

Forte Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jul 19 16:12 ET

Forte Biosciences | 8-K: Current report

Jun 14 16:10 ET

Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES FIRST QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE

May 13 16:10 ET

Forte Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 12 16:09 ET

Forte Biosciences | 8-K: Current report

Mar 18 16:22 ET

Forte Biosciences | 8-K/A: Current report (Amendment)

Feb 16 16:18 ET

Forte Biosciences | 8-K: Current report

Dec 8, 2023 16:05 ET

Forte Biosciences | 8-K/A: Current report (Amendment)

Sep 26, 2023 16:16 ET

Forte Biosciences | 8-K: Current report

Sep 20, 2023 16:15 ET

Forte Biosciences | 8-K: Current report

Sep 20, 2023 16:05 ET

Forte Biosciences | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Sep 14, 2023 16:00 ET

Forte Biosciences | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Sep 6, 2023 16:31 ET

Forte Biosciences | DEFA14A: Others

Sep 1, 2023 17:25 ET

Forte Biosciences | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Aug 31, 2023 17:29 ET

Forte Biosciences | DEFA14A: Others

Aug 31, 2023 14:31 ET

Forte Biosciences | S-3: Registration statement for specified transactions by certain issuers

Aug 29, 2023 17:57 ET